Polygenic risk of schizophrenia and cognition in a population-based survey of older adults

David T. Liebers, Mehdi Pirooznia, Fayaz Seiffudin, Katherine L. Musliner, Peter P Zandi, Fernando S Goes

Research output: Contribution to journalArticle

Abstract

Cognitive impairment is a common feature of the major psychotic disorders, with deficits often present in at risk individuals and unaffected first-degree relatives. Previous studies have suggested that polygenic risk scores (PRS) for schizophrenia (SCZ) are associated with cognitive deficits, but there has been little examination of this association in longitudinal datasets, or comparison with other disorders. We used mixed models to study the association between PRS for 4 adult onset psychiatric disorders with cross-sectional cognitive performance and longitudinal cognitive decline in 8616 older adults from the Health and Retirement Study (HRS), followed for an average of 10 years. PRS were computed for SCZ, bipolar disorder (BD), Major Depressive Disorder (MDD), and Alzheimer's disease (ALZ). SCZ PRS associated with decreased cognitive function (z = ?3.00, P = .001, ?R2 = 0.04%), which was largely driven by an association with impaired attention and orientation (z = ?3.33, P = 4.3 × 10?4, ?R2 = 0.08%). We found no effect of BD or MDD PRS on cognition, in contrast to a robust effect of the APOE4/TOMM40 locus (z = ?5.05, P = 2.2 × 10?7, ?R2 = 0.36%), which was primarily associated with impaired verbal memory (z = ?5.15, P = 1.3 × 10?7, ?R2 = 0.21%). APOE4/TOMM40 locus and the ALZ PRS, but not the PRS for SCZ, were associated with greater cognitive decline. In summary, using a large, representative sample of older adults, we found evidence for different degrees of association between polygenic risk for SCZ and genetic risk factors for ALZ on cognitive function and decline, highlighting potential differences in the pathophysiology of cognitive deficits seen in SCZ and ALZ.

Original languageEnglish (US)
Pages (from-to)984-991
Number of pages8
JournalSchizophrenia Bulletin
Volume42
Issue number4
DOIs
StatePublished - 2016

Fingerprint

Cognition
Schizophrenia
Population
Alzheimer Disease
Major Depressive Disorder
Bipolar Disorder
Surveys and Questionnaires
Retirement
Psychotic Disorders
Psychiatry
Cognitive Dysfunction
Health

Keywords

  • Alzheimer's
  • APOE4
  • Attention
  • Bipolar disorder
  • Cognition
  • Cross-disorder
  • Endophenotype
  • Major depressive disorder
  • Polygenic risk
  • Schizophrenia

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Polygenic risk of schizophrenia and cognition in a population-based survey of older adults. / Liebers, David T.; Pirooznia, Mehdi; Seiffudin, Fayaz; Musliner, Katherine L.; Zandi, Peter P; Goes, Fernando S.

In: Schizophrenia Bulletin, Vol. 42, No. 4, 2016, p. 984-991.

Research output: Contribution to journalArticle

Liebers, David T. ; Pirooznia, Mehdi ; Seiffudin, Fayaz ; Musliner, Katherine L. ; Zandi, Peter P ; Goes, Fernando S. / Polygenic risk of schizophrenia and cognition in a population-based survey of older adults. In: Schizophrenia Bulletin. 2016 ; Vol. 42, No. 4. pp. 984-991.
@article{bafa7953c8e749198d88fcf23816b294,
title = "Polygenic risk of schizophrenia and cognition in a population-based survey of older adults",
abstract = "Cognitive impairment is a common feature of the major psychotic disorders, with deficits often present in at risk individuals and unaffected first-degree relatives. Previous studies have suggested that polygenic risk scores (PRS) for schizophrenia (SCZ) are associated with cognitive deficits, but there has been little examination of this association in longitudinal datasets, or comparison with other disorders. We used mixed models to study the association between PRS for 4 adult onset psychiatric disorders with cross-sectional cognitive performance and longitudinal cognitive decline in 8616 older adults from the Health and Retirement Study (HRS), followed for an average of 10 years. PRS were computed for SCZ, bipolar disorder (BD), Major Depressive Disorder (MDD), and Alzheimer's disease (ALZ). SCZ PRS associated with decreased cognitive function (z = ?3.00, P = .001, ?R2 = 0.04{\%}), which was largely driven by an association with impaired attention and orientation (z = ?3.33, P = 4.3 × 10?4, ?R2 = 0.08{\%}). We found no effect of BD or MDD PRS on cognition, in contrast to a robust effect of the APOE4/TOMM40 locus (z = ?5.05, P = 2.2 × 10?7, ?R2 = 0.36{\%}), which was primarily associated with impaired verbal memory (z = ?5.15, P = 1.3 × 10?7, ?R2 = 0.21{\%}). APOE4/TOMM40 locus and the ALZ PRS, but not the PRS for SCZ, were associated with greater cognitive decline. In summary, using a large, representative sample of older adults, we found evidence for different degrees of association between polygenic risk for SCZ and genetic risk factors for ALZ on cognitive function and decline, highlighting potential differences in the pathophysiology of cognitive deficits seen in SCZ and ALZ.",
keywords = "Alzheimer's, APOE4, Attention, Bipolar disorder, Cognition, Cross-disorder, Endophenotype, Major depressive disorder, Polygenic risk, Schizophrenia",
author = "Liebers, {David T.} and Mehdi Pirooznia and Fayaz Seiffudin and Musliner, {Katherine L.} and Zandi, {Peter P} and Goes, {Fernando S}",
year = "2016",
doi = "10.1093/schbul/sbw001",
language = "English (US)",
volume = "42",
pages = "984--991",
journal = "Schizophrenia Bulletin",
issn = "0586-7614",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Polygenic risk of schizophrenia and cognition in a population-based survey of older adults

AU - Liebers, David T.

AU - Pirooznia, Mehdi

AU - Seiffudin, Fayaz

AU - Musliner, Katherine L.

AU - Zandi, Peter P

AU - Goes, Fernando S

PY - 2016

Y1 - 2016

N2 - Cognitive impairment is a common feature of the major psychotic disorders, with deficits often present in at risk individuals and unaffected first-degree relatives. Previous studies have suggested that polygenic risk scores (PRS) for schizophrenia (SCZ) are associated with cognitive deficits, but there has been little examination of this association in longitudinal datasets, or comparison with other disorders. We used mixed models to study the association between PRS for 4 adult onset psychiatric disorders with cross-sectional cognitive performance and longitudinal cognitive decline in 8616 older adults from the Health and Retirement Study (HRS), followed for an average of 10 years. PRS were computed for SCZ, bipolar disorder (BD), Major Depressive Disorder (MDD), and Alzheimer's disease (ALZ). SCZ PRS associated with decreased cognitive function (z = ?3.00, P = .001, ?R2 = 0.04%), which was largely driven by an association with impaired attention and orientation (z = ?3.33, P = 4.3 × 10?4, ?R2 = 0.08%). We found no effect of BD or MDD PRS on cognition, in contrast to a robust effect of the APOE4/TOMM40 locus (z = ?5.05, P = 2.2 × 10?7, ?R2 = 0.36%), which was primarily associated with impaired verbal memory (z = ?5.15, P = 1.3 × 10?7, ?R2 = 0.21%). APOE4/TOMM40 locus and the ALZ PRS, but not the PRS for SCZ, were associated with greater cognitive decline. In summary, using a large, representative sample of older adults, we found evidence for different degrees of association between polygenic risk for SCZ and genetic risk factors for ALZ on cognitive function and decline, highlighting potential differences in the pathophysiology of cognitive deficits seen in SCZ and ALZ.

AB - Cognitive impairment is a common feature of the major psychotic disorders, with deficits often present in at risk individuals and unaffected first-degree relatives. Previous studies have suggested that polygenic risk scores (PRS) for schizophrenia (SCZ) are associated with cognitive deficits, but there has been little examination of this association in longitudinal datasets, or comparison with other disorders. We used mixed models to study the association between PRS for 4 adult onset psychiatric disorders with cross-sectional cognitive performance and longitudinal cognitive decline in 8616 older adults from the Health and Retirement Study (HRS), followed for an average of 10 years. PRS were computed for SCZ, bipolar disorder (BD), Major Depressive Disorder (MDD), and Alzheimer's disease (ALZ). SCZ PRS associated with decreased cognitive function (z = ?3.00, P = .001, ?R2 = 0.04%), which was largely driven by an association with impaired attention and orientation (z = ?3.33, P = 4.3 × 10?4, ?R2 = 0.08%). We found no effect of BD or MDD PRS on cognition, in contrast to a robust effect of the APOE4/TOMM40 locus (z = ?5.05, P = 2.2 × 10?7, ?R2 = 0.36%), which was primarily associated with impaired verbal memory (z = ?5.15, P = 1.3 × 10?7, ?R2 = 0.21%). APOE4/TOMM40 locus and the ALZ PRS, but not the PRS for SCZ, were associated with greater cognitive decline. In summary, using a large, representative sample of older adults, we found evidence for different degrees of association between polygenic risk for SCZ and genetic risk factors for ALZ on cognitive function and decline, highlighting potential differences in the pathophysiology of cognitive deficits seen in SCZ and ALZ.

KW - Alzheimer's

KW - APOE4

KW - Attention

KW - Bipolar disorder

KW - Cognition

KW - Cross-disorder

KW - Endophenotype

KW - Major depressive disorder

KW - Polygenic risk

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=84979233548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979233548&partnerID=8YFLogxK

U2 - 10.1093/schbul/sbw001

DO - 10.1093/schbul/sbw001

M3 - Article

C2 - 26873889

AN - SCOPUS:84979233548

VL - 42

SP - 984

EP - 991

JO - Schizophrenia Bulletin

JF - Schizophrenia Bulletin

SN - 0586-7614

IS - 4

ER -